Alpine Global Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-104,055
Closed -$18.4M 466
2020
Q1
$18.4M Buy
104,055
+59,797
+135% +$11.3M 3.83% 6
2019
Q4
$8.46M Sell
44,258
-3,242
-7% -$585K 1.81% 6
2019
Q3
$7.99M Buy
47,500
+32,500
+217% +$5.29M 2.05% 11
2019
Q2
$2.51M Buy
+15,000
New +$2.08M 0.73% 22
2017
Q2
Sell
-5,161
Closed -$1.23M 343
2017
Q1
$1.23M Buy
+5,161
New +$1.2M 0.32% 73
2016
Q2
Sell
-19,548
Closed -$5.24M 277
2016
Q1
$5.24M Buy
19,548
+10,223
+110% +$2.93M 1.2% 20
2015
Q4
$2.91M Buy
+9,325
New +$2.78M 0.93% 21
2015
Q3
Sell
-739
Closed -$224K 964
2015
Q2
$224K Sell
739
-1,958
-73% -$584K 0.04% 355
2015
Q1
$803K Sell
2,697
-3,526
-57% -$1.01M 0.26% 86
2014
Q4
$1.6M Buy
+6,223
New +$1.56M 0.29% 85

Other funds holding AGN

Alpine Global Management's AGN Position: Q2 2020 in Review

Alpine Global Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 104,055 shares — an estimated $18.4M sold.

Alpine Global Management first reported a position in AGN in Q4 2014 and held it in 10 quarters. The position peaked at $18.4M in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Alpine Global Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Alpine Global Management sold 104,055 Allergan plc shares in Q2 2020, an estimated $18.4M.
  • Alpine Global Management first reported a position in Allergan plc in Q4 2014 and held it in 10 quarters.
  • Alpine Global Management's Allergan plc position peaked at $18.4M in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Alpine Global Management's 13F filing for Q2 2020, filed 14 Aug 2020.